Free Content Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin

Authors: Hassel, Bjørnar; Taubøll, Erik1; Shaw, Renee2; Gjerstad, Leif1; Dingledine, Ray2

Source: Epilepsia, Volume 51, Number 9, September 2010 , pp. 1714-1720(7)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Summary Purpose:

It is commonly assumed that antiepileptic drugs (AEDs) act similarly in the various parts of the brain as long as their molecular targets are present. A few experimental studies on metabolic effects of vigabatrin, levetiracetam, valproate, and lamotrigine have shown that these drugs may act differently in different brain regions. We examined effects of chronic treatment with levetiracetam or phenytoin on mRNA levels to detect regional drug effects in a broad, nonbiased manner. Methods:

mRNA levels were monitored in three brain regions with oligonucleotide-based microarrays. Results:

Levetiracetam (150 mg/kg for 90 days) changed the expression of 65 genes in pons/medulla oblongata, two in hippocampus, and one in frontal cortex. Phenytoin (75 mg/kg), in contrast, changed the expression of only three genes in pons/medulla oblongata, but 64 genes in hippocampus, and 327 genes in frontal cortex. Very little overlap between regions or drug treatments was observed with respect to effects on gene expression. Discussion:

We conclude that chronic treatment with levetiracetam or phenytoin causes region-specific and highly differential effects on gene expression in the brain. Regional effects on gene expression could reflect regional differences in molecular targets of AEDs, and they could influence the clinical profiles of AEDs.

Keywords: Epilepsy; mRNA; Transcription; Antiepileptic drugs; Brain region

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1528-1167.2010.02545.x

Affiliations: 1: Department of Neurology, Division of Clinical Neuroscience, Rikshospitalet, Oslo, Norway 2: Department of Pharmacology, Emory University, Atlanta, Georgia, U.S.A.

Publication date: 2010-09-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page